CrossrefInfokarte
A Tripartite Collaborative Model for Identifying High-Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Semaglutide Treatment Algorithm Starting With the Fibrosis-4 Index
Kanzo · 2026-11-01 · 67 (6) · 561-574
DOI: 10.2957/kanzo.67.561 ↗Abstract
Kein Abstract verfügbar.
EUVIMED